Introduction
Although community-acquired pneumonia (CAP) continues to represent a frequent condition, there are ongoing controversies about the optimal strategy of patient care. These aect all important corresponding issues, including criteria for hospitalization, diagnostic approaches, and initial antimicrobial treatment (1±6). In the era of limited health care resources, economic aspects gain increasing priority in these debates.
Current concepts of management of patients with CAP generally intend to provide a framework of advice which is evidence-based from the literature (1±4). Some of these have already been subject to prospective validation. For example, recommendations for the initial antimicrobial treatment in the guidelines of the American Thoracic Society (ATS) for the initial management of adult CAP were implemented in patient care and assessed with regard to cost-eectiveness (7) . A perhaps more simple and pragmatic way to optimize patient care could be the evaluation of routine management of CAP in distinct hospital settings. Such an evaluation may oer the opportunity to detect conceptual weaknesses which might be subject to future intervention. We thought that the most recently published European Respiratory Society (ERS) guidelines (5) and the powerful tool of Fine's severity score for CAP (8) would guide such a type of critical evaluation.
Thus, we performed a prospective study of patients with CAP in order to evaluate the severity patterns of CAP, diagnostic approaches and results as well as initial empiric antimicrobial treatment and its impact on outcome. The setting of a primary care hospital was chosen since in our region probably most hospitalized patients with CAP are treated in these hospitals.
Methods

SETTING
The study was conducted at the Dreifaltigkeits-Krankenhaus in Wesseling, a primary care hospital with approximately 200 beds. The Department of Internal Medicine does not include any speciality. The hospital does not have a microbiological laboratory on site. No attempt was made to in¯uence patient management in any phase of hospital stay.
PATIENTS
Between 1 July 1996 and 31 March 1998, all patients with a diagnosis of community-acquired pneumonia were prospectively recorded. The diagnosis of community-acquired pneumonia was based on a new in®ltrate in a chest radiograph, symptoms suggestive of a lower respiratory tract infection, and no alternative diagnosis emerging during follow-up in a non-immunosuppressed host not hospitalized during the previous month. Exclusion criteria were (i) the presence of severe immunosuppression with inherent risk of opportunistic infections (HIV infection, neutropenia 51610 9 l 71 , and organ transplantation); (ii) patients referred from another hospital after initiation of antimicrobial treatment; (iii) patients with gross aspiration; and (iv) patients with pulmonary tuberculosis.
DATA COLLECTION
All data were recorded on standard record sheets by two of the authors (K.S. and T.K.) who were members of the sta of the Department of Internal Medicine at the Dreifaltigkeits-Krankenhaus. On admission, the following demographic parameters were retrieved: age, gender, admission from home or nursing-home, smoking habits and alcohol intake, and comorbid illnesses. Physical examination parameters included respiratory rate, heart rate, systolic and diastolic blood pressure, mental confusion de®ned according to Fine et al. (8) : disorientation with respect to person, place or time that is to not known to be chronic, stupor, or coma.
Laboratory parameters included leucocyte count, lactate dehydrogenase (LDH), blood urea nitrogen, (BUN) hematocrit, sodium, glucose. Further data included: blood gases (pH, PaO 2 , PaCO 2 , PaO 2 F 1 O 2 ), extent and type of pulmonary in®ltrates (uni-vs. bilateral and alveolar vs. bronchopneumonic) as well as the presence of pleural eusion, and suspicion of gross aspiration. After discharge or death, the type of antimicrobial treatment, microbiological results and outcome variables (duration of hospitalization, requirement for ICU admission and for mechanical ventilation, survival or death within 30 days of hospital treatment) were retrieved additionally. Data were recorded on and entered into a computer database.
DEFINITIONS
Patients were classi®ed according to the severity score of Fine et al (8) . Patients with Fine scores I and II (i.e. a risk of mortality 51%) were classi®ed as having mild CAP, and those with Fine scores III±V as having moderate CAP, unless admitted to the ICU. Since no universally accepted de®nition of severe CAP is available, and Fine scores IV and V were not designed to provide such de®nition, it was de®ned as admission to the ICU within 5 days of hospital admission.
Adequacy of initial empiric antimicrobial treatment was de®ned following the ERS guidelines (5). Modi®cations were made according to current German susceptibility patterns (9) . Third or fourth generation quinolones were not used in any case and, therefore, not considered.
Since mild CAP may have been safely managed at home, antimicrobial treatment in patients presenting with mild CAP was judged according to recommendations for outpatient pneumonia. Thus, monotherapy with aminopenicillin, ®rst-generation cephalosporin, macrolide, and tetracycline was considered adequate, whereas any monotherapy with inadequate coverage of Streptococcus pneumoniae (second generation quinolones such as o¯oxacin and cipro¯oxacin) and Haemophilus in¯uenzae (pencillin G) was considered inadequate.
In moderate CAP, monotherapy with aminopenicillin or second-or third-generation cephalosporin was considered adequate. Inadequate treatment was de®ned as treatment without adequate coverage of Streptococcus pneumoniae, Haemophilus in¯uenzae and/or Gram-negative enteric bacilli (penicillin G with and without aminoglycosides, ®rst-generation cephalosporins, macrolides and cotrimoxazol). Since the regular coverage of`atypical' bacterial pathogens with a macrolide was optional in the ERS guidelines, its absence was not considered inadequate.
In severe CAP, any monotherapy and any combination treatment without coverage of`atypical' bacterial pathogens (with macrolides or second generation quinolones) was considered inadequate. In addition to ERS guidelines, aminoglycosides as part of an appropriate combination regimen were accepted.
In case of suspected aspiration, aminopenicillin +b-lactamase-inhibitor and clindamycin but also imipenem or metronidazole were considered adequate candidates for the coverage of pathogens usually associated with aspiration.
Antimicrobial overtreatment was de®ned as an adequate antimicrobial coverage which might have been equally achieved by less potent and cheaper antimicrobial agents. Particularly, since the frequency of b-lactamase-producing strains of Haemophilus in¯uenzae in Germany is low, the regular use of an aminopenicillin plus b-lactamase inhibitor was considered as over-treatment.
Non-response to initial antimicrobial treatment was de®ned as persistent fever 38?38C and/or persistent clinical symptoms (malaise, cough, expectoration or dyspnoea) or clinical deterioration (development of acute respiratory failure requiring ventilatory support and/or or septic shock) after 72 h of in-hospital antimicrobial treatment.
EVALUATION OF PATIENT MANAGEMENT
The evaluation of patient management included (i) the determination of severity patterns in the general hospitalized population and in patients admitted to the ICU; (ii) the assessment of diagnostic work-up according to severity of pneumonia; (iii) the analysis of initial antimicrobial treatment (response rate, frequency of inadequacy and antimicrobial overtreatment). Potential consequences of inadequate antimicrobial treatment were determined by its in¯uence on outcome measurements (non-response to initial antimicrobial treatment, duration of hospitalization, 30 day in-hospital mortality).
STATISTICS
Results are expressed as mean + standard deviation (SD). Continuous variables were compared by Student's t-test, and categorical variables were compared by w 2 test or by Fisher's exact test where appropriate. Comparisons of continuous variables of more than two groups were performed by one way ANOVA with post-hoc Bonferroni correction. The level of signi®cance was set at 5%.
Results
PATIENTS DESCRIPTIVES
Overall, 232 patients with CAP (mean age 69+17, range 19±93 years, 114 male, 118 female) were included in the study. Twenty-three patients (10%) were admitted from nursing-homes. A total of 120 patients (52%) had been admitted to the hospital at least once within the last 2 years (not within the last month), and 52 patients (22%) had a history of previous pneumonia within that period.
Eighty-six patients (37%) were current smokers (410 cigarettes day 71 ), and twelve (5%) were alcoholics (estimated intake of 480 g alcohol day 71 ). At least one comorbid illness was present in 182 patients (88%), including 54 (23%) with one, 86 (35%) with two, 34 (15%) with three, and 12 (5%) with four co-morbid illnesses. These included cardiac illnesses (n=133), pulmonary illnesses (n=66), arterial hypertension (n=51), CNS disorders (n=47), diabetes mellitus (n=30), neoplastic illnesses (n=23) renal illnesses (n=22), and hepatic illnesses (n=4).
HOSPITAL AND ICU ADMISSION
Eighteen patients (8%) belonged to risk class 1, 39 (17%) to risk classs II, 49 (21%) to risk class III, 92 (40%) to risk class IV, and 34 (15%) to risk class V. According to the given de®nitions, 55 hospitalized patients (24%) had mild CAP (with a mortality risk of 51%), 156 (67%) moderate, and 21 patients (9%) severe CAP. No patient required ICU admission after 5 days of hospital admission due to late complications not related to initial severity. Out of 21 patients admitted to the ICU, two were in risk class II, one in risk class III, 10 in risk class IV, and eight in risk class V. These numbers corresponded to 5%, 2%, 11%, and 24% admissions to the ICU in each risk class, respectively. Five additional patients had an indication for ICU admission during hospital treatment but were not admitted because of advanced age and debilitating illness: these were in risk classes III (n=1), IV (n=1), and V (n=3). Six of 21 patients (29%) with severe CAP required mechanical ventilation.
MICROBIAL INVESTIGATION
Blood cultures were performed in 113 (49%) patients and pleural¯uid was obtained in ®ve cases (2%): 101/180 (56%) of patients with temperature 4388C at admission had a blood culture, and 101/113 (89%) with blood culture had a temperature 4388C. Bronchoscopy with bronchoalveolar lavage (BAL) was performed in 23 (10%) patients, but only in two occasions within 24 h after hospitalization. Four bronchoscopies were performed in six mechanically ventilated patients. Sputum and serology were not done in any case. Overall, 124 patients (54%) had at least one microbial examination. There was no discernible association between the frequency of microbial investigation and risk classes (Table 1) . Moderate n (%) n=21
Severe n (%) n=21 
AETIOLOGY
A de®nite aetiology (blood culture, pleural eusion, and/or BAL performed within 24 h after hospitalization) could be determined in 11 patients. The following pathogens were identi®ed: Streptococcus pneumoniae (n=4), other Streptococci (n=1), Staphylococcus aureus (n=3), Enterobacter spp (n=2), Proteus spp (n=1). A further seven pathogens were determined by BAL performed after 24 h (probably representing nosocomial infections) in ®ve patients: Haemophilus in¯uenzae (n=1), Escherichia coli (n=1), Klebsiella spp (n=2), Enterobacter spp (n=2), Morganella spp (n=1).
Blood cultures were positive in 9/113 cases (8%), BAL in 6/23 (26%) 1/2 (50%) of those performed within 24 h after hospitalization, and pleural eusion cultures in 2/5 (40%).
AMBULATORY ANTIMICROBIAL PRE-TREATMENT
Thirty-eight patients (16%) had received ambulatory oral antimicrobial pre-treatment. This included aminopenicillin (n=5), cephalosporins (n=4), macolides (n=10), cotrimoxazole (n=2), tetracyclin (n=10) and quinolones (n=7).
INITIAL EMPIRIC ANTIMICROBIAL TREATMENT
All patients received initial empiric antimicrobial treatment shortly after admission. This included monotherapy in 175 patients (75%) and a combination regimen in 57 (25%). The latter consisted of dual combination treatment in 49 (21%) and of triple combination treatment in eight (3%) patients. The antimicrobial agents administered are summarized in Table 2 . Monotherapy was signi®cantly more frequent in mild and moderate CAP, and combination therapy in severe CAP (P50?05). Accordingly, there was a trend to administer a combination regimen in higher risk classes [ 
OUTCOME
The mean duration of hospitalization was 14?8+9?1 days. Strati®cation of the duration of hospitalization according to risk classes is given in Table 3 . Patients with severe CAP were hospitalized signi®cantly longer than those with mild and moderate CAP (mild CAP 11?4+8?7, moderate CAP 15?3+7?9 and severe CAP 19?6+13?9 days; P50?001). Accordingly, the duration of hospitalization was signi®-cantly longer in risk class IV as compared to risk class II when all patients were taken into account, and in risk classes IV and V when only survivors were included.
Fifteen patients (7%) died, including ®ve patients treated in the ICU (24%). No patient died in risk classes I and II, one in risk class III (2%), ®ve in risk class IV (5?5%), and nine in risk class V (26?5%).
Discussion
In this study evaluating routine management of CAP in a primary care hospital, two principal management policies were obvious. These included (i) an individualized diagnostic and antimicrobial treatment approach and (ii) the general limitation of diagnostic evaluation to blood cultures and occasionally pleural¯uid puncture and bronchoscopy with bronchoalveolar lavage. The application of standardized criteria in the evaluation of this practice resulted in several important insights: (i) 1/4 (25%) of the hospitalized patient population had a mortality risk 51% and, therefore, may have been treated preferably as outpatients; (ii) diagnostic testing was not applied according to severity of CAP; (iii) whereas in mild CAP inadequate antimicrobial treatment was rare and overtreatment relatively frequent, the reverse was true for severe CAP; (iv) inadequate antimicrobial treatment was present in 27% of patients, and was associated with a higher primary treatment failure and longer duration of hospitalization but not with increased mortality.
The population studied was comparable to the two largest corresponding unicentre series on CAP reported in the literature in terms of age, sex, and comorbidity (10, 11) . Also the overall response rate to initial antimicrobial treatment (79%) was similar to other reports (12, 13) . The de®nition of severe CAP may be subject to concern sincè admission to the ICU' does not represent an independent criterion. However, no universally accepted de®nition of severe CAP is available, and all series dealing with severe CAP in the literature refer to patients admitted to the ICU. In fact, the mortality of 7% in the general population and 24% in severe CAP was in the range of the expected (14± 17). Finally, mortality rates were very similar to those found by Fine et al. for the MedisGroups and inpatients Port validation cohorts (0, 0, 2?0, 5?5 and 26?6% for risk classes I±V in our study as compared to 0, 0?6, 2?8, 8?2 and 29?2 and 0, 0?9, 1?2, 9?0 and 27?1%, respectively) (8) .
One of the most striking ®ndings in this evaluation of management of patients with CAP was the high proportion of hospitalized patients who may have been primarily candidates for ambulatory treatment. Consistent with another recent report (18) , social reasons may have impeded ambulatory treatment in some cases and, as a matter of fact, two patients with risk class II required admission to the ICU. Unfortunately, the study design did not allow determination of the exact rate of extramedical reasons for hospital admissions in our series. Nevertheless, our data suggest that the implementation of the criteria for the identi®cation of patients at low risks as de®ned by Fine et al. in general practice and primary hospitals bears a considerable potential for cost saving.
The regular diagnostic approach of hospitalized patients did not include sputum, serology and antigen-testing but was con®ned to blood cultures and pleural¯uid puncture where appropriate. Therefore, the ®ndings of this study are applicable only to settings with similar diagnostic facilities. The rationale of recommending blood cultures only in patients with a temperature 4388C in the ERS guidelines may be questioned. In any case, blood cultures were only slightly more frequently obtained in patients with a temperature 4388C, nevertheless, the diagnostic yield of blood cultures was 8% and, thereby, in the expected range (19, 20) . Bronchoscopy was applied individually, mainly in patients with primary treatment failures or with suspected obstructing bronchial tumours. Cultures of BALF were qualitative only, however, the recommendation in the ERS guidelines to use quantitative cultures at least in mechanically ventilated patients is not supported by evidence from prospective studies. In this series, the yield of qualitative BALF cultures was considerably low (16%), con®rming the few data available in the literature (21, 22) . The diagnostic evaluation was not extended in patients with higher risk classes. Overall, the diagnostic policy used in this hospital must be interpreted on the background of the absence of a local microbiological laboratory and the prospect of having to send any respiratory secretions by mail. Whether this practice is cost-eective under the given circumstances remains to be determined. Surprisingly, positive results of blood cultures and bronchoscopy were not signi®cantly more likely in higher risk classes. Although it is not possible to argue in favour of a risk-adapted diagnostic work-up in light of the results of the present study, it seems reasonable to assume that patients with severe CAP have the highest bene®t from diagnostic results (22) .
Overtreatment was found to be frequent in mild and moderate CAP. The majority of overtreatment was due to monotherapy with aminopenicillins including b-lactamase inhibitors and combination regimen including aminoglycosides. This apparent trend for extended or double coverage in patients with non-severe CAP, especially with aminoglycosides, clearly should be discouraged.
Adequacy of the initial empiric antimicrobial treatment was classi®ed according to ERS guidelines and modi®ed according to susceptibility patterns reported from dierent German regions (9) . Following these criteria, it was found to be inadequate in a considerable amount of cases (27%). The particularly high rate of inadequate antimicrobial treatment in patients with severe CAP represents a serious concern. However, in the absence of a de®ned microbial pattern of the local setting, any classi®cation of the initial (23) and another with cipro¯oxacin in severe CAP (13) . Moreover, monotherapy with macrolides in hospitalized patients not admitted to the ICU may be adequate in a population with a low incidence of Haemophilus in¯uenzae and GNEB, whereas the absence of macrolides in severe CAP may equally represent an adequate regimen in a population with a low incidence of atypical' pathogens, particularly of legionellosis. Nevertheless, having these limitations in mind, inadequate initial antimicrobial treatment was associated with a higher proportion of primary treatment failures and a longer duration of hospitalization. These dierences were most pronounced in the group with severe CAP. These ®ndings clearly indicate that inadequate antimicrobial treatment does aect outcome measurements which bear important economic implications. On the other hand, in contrast to ®ndings of others in patients with severe CAP (24,25), we did not ®nd a signi®cant association of inadequate initial antimicrobial treatment with mortality. However, in view of the limited number of deaths in this series, this lacking association should be interpreted with caution.
In conclusion, the main prospects for a future interventional study are the consideration of ambulatory treatment in low risk patients and the reduction of overtreatment in hospitalized patients with non-severe CAP. The eect of extended microbial investigation on the outcome of severe CAP remains to be determined. Finally, current antimicrobial treatment guidelines may be useful in terms of optimizing cost-eectiveness in the management of patients with CAP.
